FDA Framework For Personalized Therapies Raises Questions
On Feb. 23, the U.S. Food and Drug Administration issued a highly anticipated draft guidance that details a new regulatory approach — the plausible mechanism framework — for the development of...To view the full article, register now.
Already a subscriber? Click here to view full article